Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S(TSE:PFE)
CA$13.05+0.05 (+0.38%)
TSE:PFE
Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S stock analysis
CA$13.05
At close:+0.05 (+0.38%)
Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S (PFE) Stock Price & Analysis
6 Followers
PFE Stock Chart & Stats
CA$13.05CA$0.05(0.38%)
At close: 4:00 PM EST
- Day’s Range
- CAD 12.85 - CAD 13.07
- 52-Week Range
- CAD 10.57 - CAD 13.94
- Previous Close
- CAD 13.00
- Volume
- N/A
- Average Volume (3M)
- 115.26K
- Market Cap
- CAD 238.48B
- Enterprise Value
- CAD 142.52B
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- 41.7
- Beta
- 0.43
- Next Earnings
- Feb 02, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Nov 06, 2026
- Dividend Yield
- 5.88%
Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S News
PFE FAQ
What was Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s price range in the past 12 months?
Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S lowest stock price was C$10.57 and its highest was C$13.94 in the past 12 months.
What is Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s market cap?
Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s market cap is C$238.48B.
When is Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s earnings last quarter?
Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S released its earnings results on Nov 03, 2026. The company reported C$0.789 earnings per share for the quarter.
Is Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S pay dividends?
Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S pays a dividend of C$0.19 which represents an annual dividend yield of 5.88%. See more information on Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S dividends here
What is Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s EPS estimate?
Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S have?
Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S has 5,699,853,500 shares outstanding.
What happened to Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s price movement after its last earnings report?
Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S reported an EPS of C$0.789 in its last earnings report. Following the earnings report the stock price went down -2.274%.
Which hedge fund is a major shareholder of Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S?
Currently, no hedge funds are holding shares in TSE:PFE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
- Sector
- General
- Industry
- Drug Manufacturers - General
- CEO
- Albert Bourla
- Employees
- 75,000
- Website
- www.pfizer.com
- Address
- 66 Hudson Boulevard East, New York City, NY, 10001-2192, US
Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S (PFE) Earnings & Revenues
PFE Earnings Call
Q3 2026
Earnings Call SentimentPositive
The call was strongly positive overall. Highlights significantly outweighed the lowlights, with robust operational growth in launched and acquired products, raised 2026 revenue and EPS guidance, substantial cost savings, strong cash generation, and multiple encouraging clinical and regulatory developments. The main challenges were declining COVID-19 revenue, upcoming loss-of-exclusivity pressures, policy and pricing factors, and selected clinical-readout delays.
View all TSE:PFE earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 10 | 5 | 7 |
| Technical Analysis | 2 | 5 | 3 |
| Moving Averages | 8 | 0 | 4 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| TSE:NVSNovartis AG CAD Hedged CIBC CDR | ||
| TSE:SNYSanofi SA Unsponsored CDR Hedged Reg S | ||
| TSE:MRKMerck & Co., Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S | ||
| TSE:GILDGilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S | ||
| TSE:AMGNAmgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S |
